Overview / Abstract: |
Target Audience The target audience for this educational initiative is primary care providers (physicians, nurse practitioners, and physician assistants) and neurologists, particularly community neurologists. Program Overview Alzheimer’s disease (AD) is the most common cause of dementia, with growing prevalence as the United States population ages. In older adults, the differences between normal age-related cognitive changes and the cognitive changes of Alzheimer’s dementia can be subtle; as such, the diagnosis of early AD requires clinicians to accurately assess and track patient cognition, function, and behavior over time through the effective use of validated assessment tools. However, despite modern clinical advancements evolving our understanding of AD, many patients with AD are either misdiagnosed or diagnosed late in the course of disease, and as a result may not be recognized for inclusion in ongoing clinical trials. Join our expert faculty as they provide you with key insights surrounding multiple unique patient scenarios designed to challenge your knowledge of available assessment tools for multiple domains of AD, while assessing their strengths, limitations, and suitability in different patient scenarios. Learning Objectives Upon completion of this activity, participants should be better able to: DESCRIBE the strengths and limitations of assessment tools used in clinical practice and clinical research settings for the screening and diagnosis of early AD. |
Expiration |
Jan 24, 2023 |
Discipline(s) |
Physician CME |
Format |
Online |
Credits / Hours |
.50 |
Accreditation |
ACCME |
Presenters / Authors / Faculty |
R. Scott Turner, MD, PhD |
Sponsors / Supporters / Grant Providers |
Biogen MA, Inc |
Keywords / Search Terms |
Relias LLC Relias LLC Relias, Free CME, Alzheimer's Disease Free CE CME Free CE CME |